- Home
- SPRY vs ARR Comparison
SPRY vs ARR Comparison
Compare SPRY & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- ARR
- Stock Information
- Founded
- SPRY 2015
- ARR 2008
- Country
- SPRY United States
- ARR United States
- Employees
- SPRY N/A
- ARR N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- ARR Real Estate Investment Trusts
- Sector
- SPRY Health Care
- ARR Real Estate
- Exchange
- SPRY Nasdaq
- ARR Nasdaq
- Market Cap
- SPRY 1.4B
- ARR 1.4B
- IPO Year
- SPRY N/A
- ARR N/A
- Fundamental
- Price
- SPRY $14.16
- ARR $16.09
- Analyst Decision
- SPRY Strong Buy
- ARR Hold
- Analyst Count
- SPRY 4
- ARR 5
- Target Price
- SPRY $28.75
- ARR $21.00
- AVG Volume (30 Days)
- SPRY 1.5M
- ARR 2.3M
- Earning Date
- SPRY 05-14-2025
- ARR 07-23-2025
- Dividend Yield
- SPRY N/A
- ARR 17.77%
- EPS Growth
- SPRY N/A
- ARR N/A
- EPS
- SPRY N/A
- ARR N/A
- Revenue
- SPRY $97,122,000.00
- ARR $44,778,000.00
- Revenue This Year
- SPRY $1.49
- ARR $532.77
- Revenue Next Year
- SPRY $141.68
- ARR $15.62
- P/E Ratio
- SPRY N/A
- ARR N/A
- Revenue Growth
- SPRY 971120.00
- ARR 41.14
- 52 Week Low
- SPRY $7.55
- ARR $13.18
- 52 Week High
- SPRY $18.51
- ARR $21.93
- Technical
- Relative Strength Index (RSI)
- SPRY 50.86
- ARR 45.21
- Support Level
- SPRY $14.32
- ARR $15.61
- Resistance Level
- SPRY $15.50
- ARR $16.88
- Average True Range (ATR)
- SPRY 0.84
- ARR 0.29
- MACD
- SPRY 0.06
- ARR -0.05
- Stochastic Oscillator
- SPRY 65.19
- ARR 30.07
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.